zepbound eli lilly news - Search News

food and drug administration, Lilly

The Wall Street Journal on MSN · 2h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

Barron's on MSN · 13h

Eli Lilly’s Weight-Loss Drugs No Longer In Shortage. It’s Bad News for These Stocks.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

USA Today · 5h

Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit cheaper copycat versions.

Zacks.com on MSN6h

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

ConsumerAffairs8h

Mountjaro, Zepbound removed from FDA's shortage list

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

15hon MSN

Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion

The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...

1d

Mounjaro and Zepbound no longer in shortage

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results